Skip to main content

Home/ Groups/ Medicine & Healthcare
avivajazz  jazzaviva

OrbusNeich "Genous" Bioengineered R Stent is Safe Alternative to Drug-Eluting Stents - 0 views

  •  
    Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents (Randomized TRIAS HR Pilot Study)
avivajazz  jazzaviva

ScienceDirect - Clinical Biochemistry : Ameliorating effect of coenzyme Q10, riboflavin... - 0 views

  •  
    ffect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins
avivajazz  jazzaviva

The Truth about Drug Companies - 0 views

  •  
    There is no simple way to preserve the entrepreneurial spirit that has created MRI scans, stents, bioengineered drugs, and artificial knees - and completely eliminate financial conflicts of interest...Even with rigorous guidelines, pharmaceutical companie
avivajazz  jazzaviva

Cardiovascular Drug Discoveries 2008: What's in the Pipeline - 0 views

  •  
    Generx (alferminogene tadenovec, Ad5FGF-4) from Cardium Therapeutics, which is in Phase III for myocardial ischaemia & angina. Darapladib from GSK inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2).
avivajazz  jazzaviva

Thrombosis and Drug-Eluting Stents: An Objective Appraisal - 0 views

  •  
    Thrombosis and Drug-Eluting Stents: An Objective Appraisal
avivajazz  jazzaviva

COURAGE Quality-of-Life Analysis: Slim Early Gains With PCI Soon Disappear. (QoL) anal... - 0 views

  •  
    Percutaneous coronary intervention (PCI) can often be deferred in patients with stable coronary artery disease (CAD) and significant coronary lesions without adding risk while optimal medical therapy (OMT) is given a chance to work, and it can be consider
avivajazz  jazzaviva

Abbott Laboratories: Bioabsorbable Drug-Eluting Coronary Stent: March 24, 2007 - 0 views

  •  
    Abbott Announces Positive Six-Month Results from the World's First Clinical Trial of A Fully Bioabsorbable Drug-Eluting Coronary Stent\nAbbott's Bioabsorbable Stent Technology Holds Promise as Future-Generation Treatment Option for Physicians Treating Pati
« First ‹ Previous 321 - 340 of 799 Next › Last »
Showing 20 items per page